Purity Potency Identity
Mentions in press and media 9
| Date | Title | Description |
| 17.12.2024 | Long-term Effects with Repeated ProTrans Treatment After 6 Years | Long-term Effects with Repeated ProTrans Treatment After 6 Years Tue, Dec 17, 2024 12:50 CET Report this content NextCell Pharma AB reports new results from the ProTrans-Repeat study, where type 1 diabetes patients have been followed for 5 ... |
| 05.12.2024 | NextCell Pharma changes Certified Adviser to Redeye AB | NextCell Pharma changes Certified Adviser to Redeye AB Thu, Dec 05, 2024 08:45 CET Report this content NextCell Pharma has entered into an agreement with Redeye AB regarding the service as Certified Adviser. Redeye AB will take over as Cert... |
| 26.11.2024 | QVance and Royale International: A New Era in Cell and Gene Therapy Logistics | In the fast-paced world of biotechnology, partnerships can be the lifeblood of innovation. Recently, QVance, a subsidiary of NextCell Pharma, announced a significant collaboration with Royale International. This partnership aims to revoluti... |
| 25.11.2024 | QVance Announces Partnership with Royale International to Drive Innovation in End-to-End Cell and Gene Therapy Cold Chain Distribution and Quality Control | QVance Announces Partnership with Royale International to Drive Innovation in End-to-End Cell and Gene Therapy Cold Chain Distribution and Quality Control Mon, Nov 25, 2024 08:30 CET Report this content QVance has today announced that it ha... |
| 25.11.2024 | QVance’s Partnerships Driving Innovation in Advanced Therapies | QVance’s Partnerships Driving Innovation in Advanced Therapies Mon, Nov 25, 2024 08:45 CET Report this content NextCell Pharma AB*, parent company of QVance, proudly supports QVance’s newly announced partnership with Royale International. T... |
| 19.11.2024 | QVance and bioMérieux: A New Era in Nordic Quality Control for Advanced Therapies | In the fast-paced world of biotechnology, partnerships can be the lifeblood of innovation. On November 18, 2024, QVance AB, a Swedish startup, announced a significant partnership with bioMérieux Sweden AB. This collaboration aims to elevate... |
| 18.11.2024 | QVance Announces Partnership | QVance Announces Partnership Mon, Nov 18, 2024 08:50 CET Report this content NextCell Pharma AB* comments on its subsidiary QVance’s partnership with bioMérieux Sweden AB, which aims to strengthen quality control analytics for cell and gene... |
| 18.11.2024 | QVance AB Announces Nordic Partnership with bioMérieux | QVance AB Announces Nordic Partnership with bioMérieux Mon, Nov 18, 2024 08:45 CET Report this content QVance AB, Huddinge, Sweden has today announced it has entered into a partnership with bioMérieux Sweden AB, aimed at enhancing the quali... |
| 08.11.2024 | QVance AB publishes particulates article in collaboration with ISCT | QVance AB publishes particulates article in collaboration with ISCT Fri, Nov 08, 2024 08:45 CET Report this content QVance AB, Huddinge, Sweden has today announced its co-founder and CSO at parent company, NextCell Pharma AB, Dr Lindsay Dav... |